Systolic anterior motion of the mitral valve (SAM) occurs intraoperatively after mitral valve repair (MVRr) in up to 14% of cases and typically resolves in the operating room with conservative ...measures. Less commonly SAM may also occur in the early or late postoperative period. The clinical course and optimal management of such cases is poorly defined, but reoperation is common. We describe our experience using disopyramide to successfully treat postoperative SAM refractory to beta blockade. Seven patients were retrospectively identified with mitral valve prolapse who underwent MVRr from 2003 to 2015 and were found during follow-up to have severe SAM with a left ventricular outflow tract (LVOT) gradient not observed intraoperatively. All 7 patients were successfully managed medically. In 5 cases, SAM persisted even after maximization of beta blockade, and the addition of disopyramide led to significant improvement or resolution of SAM, the LVOT gradient, and mitral regurgitation. The postoperative LVOT gradient initially exceeded 30 mm Hg in 6 of 7 patients. In 2 patients, the LVOT gradient exceeded 100 mm Hg, and both were managed medically with disopyramide with complete resolution of SAM. In conclusion, SAM after MVRr typically follows a benign clinical course and can be managed medically in most cases. When an initial treatment strategy of beta blockade is insufficient, the addition of disopyramide can effectively alleviate and terminate this condition and should be considered before reoperation.
Artificial intelligence (AI) has been developed for echocardiography
, although it has not yet been tested with blinding and randomization. Here we designed a blinded, randomized non-inferiority ...clinical trial (ClinicalTrials.gov ID: NCT05140642; no outside funding) of AI versus sonographer initial assessment of left ventricular ejection fraction (LVEF) to evaluate the impact of AI in the interpretation workflow. The primary end point was the change in the LVEF between initial AI or sonographer assessment and final cardiologist assessment, evaluated by the proportion of studies with substantial change (more than 5% change). From 3,769 echocardiographic studies screened, 274 studies were excluded owing to poor image quality. The proportion of studies substantially changed was 16.8% in the AI group and 27.2% in the sonographer group (difference of -10.4%, 95% confidence interval: -13.2% to -7.7%, P < 0.001 for non-inferiority, P < 0.001 for superiority). The mean absolute difference between final cardiologist assessment and independent previous cardiologist assessment was 6.29% in the AI group and 7.23% in the sonographer group (difference of -0.96%, 95% confidence interval: -1.34% to -0.54%, P < 0.001 for superiority). The AI-guided workflow saved time for both sonographers and cardiologists, and cardiologists were not able to distinguish between the initial assessments by AI versus the sonographer (blinding index of 0.088). For patients undergoing echocardiographic quantification of cardiac function, initial assessment of LVEF by AI was non-inferior to assessment by sonographers.
Dissimilar atrial rhythms describe the coexistence of atrial fibrillation in one atrium and a more regular rhythm in the other. Electrograms are typically used to diagnose this rare entity. The use ...of transesophageal echocardiography in this context has not been described previously. We present a case of an 88-year-old woman with paroxysmal atrial fibrillation and new-onset, symptomatic atrial flutter who underwent electrophysiology study that confirmed dissimilar atrial rhythms. Transesophageal echocardiography images reveal differential function of the left and right atrial appendages, a novel finding that may be useful in diagnosing this rhythm disorder.
Des rythmes atriaux dissimilaires montrent la coexistence d’une fibrillation auriculaire dans un atrium et un rythme plus régulier dans l’autre. Les électrogrammes sont généralement utilisés pour détecter cette entité rare. L’utilisation de l’échocardiographie transœsophagienne dans ce contexte n’a pas été décrite auparavant. Nous présentons le cas d’une femme de 88 ans atteinte de fibrillation auriculaire paroxystique et de flutter auriculaire symptomatique d’apparition récente dont l’étude électrophysiologique a permis de confirmer des rythmes atriaux dissimilaires. Les images de l’électrocardiographie transœsophagienne révèlent le fonctionnement distinct des appendices auriculaires gauche et droite, une nouvelle observation qui peut être utile à la détection de cette irrégularité du rythme.
Abstract
Background
The echocardiographic determination of cardiac causes of stroke focuses on the presence of left ventricular thrombus, valvular vegetations, and patent foramen ovale. ...Transoesophageal echocardiogram (TEE) is indicated when the transthoracic echocardiogram (TTE) is inconclusive or when there is clinical suspicion of cardiac causes that may have been missed by TTE. The presence of severe diastolic dysfunction on TTE in the absence of any other cardiac abnormality or cardiac history is not usually considered a clue to the cause of stroke.
Case summary
This is a case of a 52-year-old woman who presented with a stroke. Transthoracic echocardiogram was inconclusive for source of embolus. Transoesophageal echocardiogram revealed left atrial appendage (LAA) thrombus and severely hypokinetic LAA, despite the patient being in normal sinus rhythm (NSR). Retrospective analysis of diastolic function on the prior TTE revealed severe restrictive diastolic dysfunction with evidence of elevated left ventricular end-diastolic pressure. While technetium pyrophosphate scan was negative, magnetic resonance imaging was consistent with cardiac amyloid and further testing revealed multiple myeloma as the cause of the amyloid light chain amyloidosis. This case highlights the importance of scrutinizing diastolic function in patients with a source of embolus and careful assessment for LAA thrombus on TEE, despite NSR.
Discussion
We present a patient with stroke with inconclusive TTE findings and eventual diagnosis of restrictive cardiomyopathy secondary to cardiac amyloidosis from an undiagnosed multiple myeloma. Severe restrictive diastolic function on TTE may be a clue to the discovery of LAA thrombus on TEE.
Background
Controversy surrounds the cause of the pressure gradient in patients with hypertrophic obstructive cardiomyopathy (HOCM). Left ventricular cavity obliteration (LVCO) was first described as ...the cause of the gradient but subsequently systolic anterior motion (SAM) of the mitral valve has been established as the cause. Nevertheless, the two gradients, though different in origin and significance, share similar characteristics. They both have a similar “dagger” profile, are obtained from the cardiac apex, are associated with a hyperdynamic left ventricle, and the gradients are worsened by Valsalva. The distinction has clinical relevance, because treating the intracavitary gradient (ICG) of LVCO as if it were a SAM‐associated gradient associated with HOCM would be inappropriate and possibly harmful.
Materials and Methods
To clarify the cause and characteristics of the ICG in patients with LVCO in patients without HOCM, we assessed the extent and duration of cavity obliteration, and for differentiation, we compared the spectral profiles with patients with HOCM and severe aortic stenosis (AS).
Results
Higher ICG is associated with a greater extent and more prolonged apposition of LV walls, and smaller left ventricular cavity size.
The spectral profile of patients with AS, HOCM, and LVCO is differentiated by the peak/mean gradient ratios of 2 or less, 2–3, and 3 or greater, respectively, in >90% of patients. Most patients with LVCO without HOCM or severe LVH have an ICG < 36 mm Hg.
Conclusion
The magnitude of ICG is quantitatively associated with the extent and duration of LVCO. Spectral profiles of severe AS, HOCM, and LVCO can be differentiated by the peak/mean gradient ratio.
Dissimilar atrial rhythms describe the coexistence of atrial fibrillation in one atrium and a more regular rhythm in the other. Electrograms are typically used to diagnose this rare entity. The use ...of transesophageal echocardiography in this context has not been described previously. We present a case of an 88-year-old woman with paroxysmal atrial fibrillation and new-onset, symptomatic atrial flutter who underwent electrophysiology study that confirmed dissimilar atrial rhythms. Transesophageal echocardiography images reveal differential function of the left and right atrial appendages, a novel finding that may be useful in diagnosing this rhythm disorder. Résumé: Des rythmes atriaux dissimilaires montrent la coexistence d’une fibrillation auriculaire dans un atrium et un rythme plus régulier dans l’autre. Les électrogrammes sont généralement utilisés pour détecter cette entité rare. L’utilisation de l’échocardiographie transœsophagienne dans ce contexte n’a pas été décrite auparavant. Nous présentons le cas d’une femme de 88 ans atteinte de fibrillation auriculaire paroxystique et de flutter auriculaire symptomatique d’apparition récente dont l’étude électrophysiologique a permis de confirmer des rythmes atriaux dissimilaires. Les images de l’électrocardiographie transœsophagienne révèlent le fonctionnement distinct des appendices auriculaires gauche et droite, une nouvelle observation qui peut être utile à la détection de cette irrégularité du rythme.
Although electrocardiographic (ECG) abnormalities and autopsy evidence of myocardial necrosis are associated with subarachnoid hemorrhage, their relation to in vivo measures of left ventricular ...function in this condition has not been established. Thirteen patients with subarachnoid hemorrhage and no prior history of heart disease were studied by two-dimensional echocardiography, performed initially 10 to 48 h (mean 18) after admission and serially for ≤14 days. Serum creatine kinase (total and myocardial isoenzyme) was determined 5 times over the first 48 h; ECGs were performed daily. Neurologic state was assessed with the use of a standard grading system.
Four patients (Group I) exhibited left ventricular wall motion abnormalities in one to eight segments. In two of these patients there was also left ventricular apical mural thrombus that embolized in one patient, leading to further neurologic deterioration. The initial creatine kinase myocardial isoenzyme was higher in Group I than in Group II (patients without wall motion abnormalities) (10.3 versus 2.1 U/liter, p < 0.001), initial heart rate was higher (91 versus 61 beats/min, p < 0.01), neurologic grade was higher (2.5 to 4.5 versus 1 to 2, p < 0.001) and inverted T waves were more common (4 of 4 versus 1 of 9). Three of the four patients in Group I died; two of the three underwent autopsy and were found to have no significant coronary artery disease. No other patients died.
From this series it appears that subarachnoid hemorrhage with a high neurologic grade is often accompanied by left ventricular wall motion abnormalities that may contribute to morbidity and mortality in such patients. These abnormalities are readily detected by two-dimensional echocardiography.
The effects of oral disopyramide 150 mg 4 times a day were compared with propranolol 40 mg 4 times a day and placebo in 10 patients with hypertrophic cardiomyopathy and resting obstruction (7 ...patients) or latent obstruction (3 patients), in a randomized double-blind crossover design; each drug was given for a period of 4 days. As determined from echocardiographic evaluation of systolic anterior motion of the mitral valve, the subaortic pressure gradient was decreased from 61 +/- 20 mm Hg with placebo to 5 +/- 15 mm Hg with disopyramide (p less than 0.01), and 30 +/- 30 mm Hg with propranolol (p less than 0.01). Disopyramide was more effective than propranolol (p less than 0.01). Disopyramide and propranolol both shortened left ventricular ejection time from 352 +/- 51 ms with placebo to 314 +/- 26 and 322 +/- 41 ms, respectively (p less than 0.01). Preejection period was lengthened from 93 +/- 35 ms with placebo to 119 +/- 25 ms with disopyramide, but was unchanged by propranolol at 98 +/- 23 ms. Disopyramide increased exercise duration versus placebo (10.4 +/- 2 vs 9.6 +/- 2 minutes, respectively (p less than 0.05), whereas propranolol produced no significant change (8.8 +/- 2 minutes).
Risk factors for erectile dysfunction (ED) (hypertension, diabetes, smoking, lipid abnormality) are also risk factors for coronary artery disease. However, most cardiologists do not routinely ask ...about ED and patients often are reluctant or embarrassed to discuss it. We determined how common ED was in a group of patients with chronic stable coronary artery disease.
We administered the validated Sexual Health Inventory for Men (SHIM) 5-item questionnaire, based on the International Index of Erectile Function questionnaire, to 76 men with chronic stable coronary artery disease during routine outpatient cardiology visits. Most of these men had not previously discussed ED with their cardiologist.
The mean patient age was 64 years (range 40 to 82). The questionnaire took about 5 minutes to complete. Of the patients 47% were on beta blockers, 92% statins, 28% diuretics. SHIM score was 21 or less in 53 men (70%), which is indicative of ED. Of the patients 75% had some difficulty achieving erections (question 2) and 67% had some difficulty maintaining an erection after penetration (question 3). The questionnaire reflected successful sildenafil treatment in 4 patients (SHIM scores 23 to 25). If these 4 men are included as having had ED then 57 of 76 (75%) had ED or recent history of ED.
ED is extremely common in men with chronic coronary artery disease (affecting approximately 75%) yet most cardiologists do not ask about it. The SHIM is a useful, quick and inexpensive tool for discussion and diagnosis of ED in this population. Although it is well established that cardiovascular risk factors are associated with erectile dysfunction, once it is present there is mixed information on whether treating the risk factors will treat the ED. Problems appear to be that lifestyle modification in midlife may simply be too late to effect a change, and some antihypertensive and lipid lowering drugs may actually exacerbate ED. Oral therapy for ED, namely the PDE5 inhibitors, is effective and safe in most cardiac and hypertensive patients. Organic nitrates such as nitroglycerin remain a contraindication to the concomitant use of these drugs. Guidelines for treatment of ED in the cardiac patient issued by the American College of Cardiology/American Heart Association and Princeton Guidelines may be useful in the approach to the cardiac patient with ED.